Dirk Trauner Selected Research

Photophobia (Light Sensitivity)

1/2022	Photoactivation of a Mechanosensitive Channel.
1/2020	Transformation of Receptor Tyrosine Kinases into Glutamate Receptors and Photoreceptors.
1/2017	Optical control of AMPA receptors using a photoswitchable quinoxaline-2,3-dione antagonist.
10/2014	Optical control of insulin release using a photoswitchable sulfonylurea.
3/2014	A photochromic agonist for μ-opioid receptors.
2/2014	Restoring visual function to blind mice with a photoswitch that exploits electrophysiological remodeling of retinal ganglion cells.
7/2011	LiGluR restores visual responses in rodent models of inherited blindness.
10/2009	New photochemical tools for controlling neuronal activity.
4/2008	Photochemical control of endogenous ion channels and cellular excitability.
12/2004	Light-activated ion channels for remote control of neuronal firing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dirk Trauner Research Topics

Disease

10	Photophobia (Light Sensitivity) 01/2022 - 12/2004
6	Neoplasms (Cancer) 01/2021 - 11/2012
2	Pain (Aches) 01/2021 - 02/2012
2	Parkinson Disease (Parkinson's Disease) 12/2017 - 01/2017
2	Breast Neoplasms (Breast Cancer) 07/2015 - 11/2012
1	Mental Disorders (Mental Disorder) 01/2022
1	Multiple Sclerosis 05/2019
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 12/2018
1	Edema (Dropsy) 01/2018
1	Ischemia 01/2018
1	Mood Disorders (Mood Disorder) 12/2017
1	Schizophrenia (Dementia Praecox) 12/2017
1	Blindness (Hysterical Blindness) 11/2017
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 11/2017
1	Retinal Degeneration 06/2017
1	Retinal Diseases 06/2017
1	Synucleinopathies 01/2017
1	Nausea 12/2015
1	Dehydration (Water Stress) 11/2015
1	Hypoxia (Hypoxemia) 07/2015
1	Neoplasm Metastasis (Metastasis) 11/2012
1	Chronic Pain 02/2012
1	Photosensitivity Disorders (Photodermatitis) 02/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2009
3	Adenosine Triphosphatases (ATPase)IBA 07/2015 - 11/2012
3	Ion Channels (Ion Channel)IBA 02/2012 - 12/2004
2	Pharmaceutical PreparationsIBA 01/2022 - 02/2014
2	Retinaldehyde (Retinal)IBA 11/2017 - 06/2017
2	azobenzeneIBA 06/2017 - 03/2014
2	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 07/2015 - 01/2013
2	Proton Pumps (Proton Pump)IBA 01/2013 - 11/2012
1	Serotonin ReceptorsIBA 01/2022
1	Biological ProductsIBA 01/2022
1	Lipid NanoparticlesIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	GlycosphingolipidsIBA 04/2020
1	Galactosylceramides (Galactocerebrosides)IBA 04/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	CeramidesIBA 05/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2018
1	TRPC6 Cation ChannelIBA 01/2018
1	SH045IBA 01/2018
1	Dopamine Receptors (Dopamine Receptor)IBA 12/2017
1	LigandsIBA 06/2017
1	SynucleinsIBA 01/2017
1	AMPA Receptors (AMPA Receptor)IBA 01/2017
1	IncretinsIBA 12/2015
1	portentolIBA 11/2015
1	IronIBA 07/2015
1	Therapeutic UsesIBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 07/2015
1	Hormones (Hormone)IBA 10/2014
1	ErbB Receptors (EGF Receptor)IBA 11/2012
1	Adenosine Triphosphate (ATP)IBA 11/2012
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 11/2012
1	Local AnestheticsIBA 02/2012
1	melanopsinIBA 07/2011
1	OpsinsIBA 07/2011
1	Glutamate Receptors (Glutamate Receptor)IBA 10/2009

Therapy/Procedure

3	Therapeutics 12/2015 - 01/2013
1	Immunotherapy 04/2020
1	Phototherapy (Light Therapy) 01/2019
1	Photochemotherapy (Photodynamic Therapy) 01/2019
1	Organ Transplantation 01/2018